Convegni & Meeting
Leprecan Like 1 (Leprel1) a prolyl-3-hydroxylase, but not Leprel2 or Leprecan, is a novel target for epigenetic silencing in multiple myeloma
Posted on 9 dicembre 2014
Hatzimichael E, Dasoula A, Lo Nigro C, Lattanzio L, Syed N, Merlano M, Bourantas K, Crook T: “Leprecan Like 1 (Leprel1) a prolyl-3-hydroxylase, but not Leprel2 or Leprecan, is a novel target for epigenetic silencing in multiple myeloma”. Lymphoma and Myeloma Meeting, NYC, USA, 21-23 ottobre 201
P3H collagen prolyl hydroxylases are tissue selective tumour suppressors
Posted on 9 dicembre 2014
Lo Nigro C, Lattanzio L, Syed N, Monteverde M, Dasoula A, Hatzimichael E, Papoudou-Bai A, Schmid P, Merlano M, Crook T: “P3H collagen prolyl hydroxylases are tissue selective tumour suppressors”, 35th ESMO Congress, Milano, 8-12 ottobre 2010 (poster discussion).
P3H collagen prolyl hydroxylases are tissue selective tumour suppressors
Posted on 9 dicembre 2014
Lo Nigro C, Lattanzio L, Syed N, Monteverde M, Dasoula A, Hatzimichael E, Papoudou-Bai A, Schmid P, Merlano M, Crook T: “P3H collagen prolyl hydroxylases are tissue selective tumour suppressors”. 52 Congresso Nazionale della Società Italiana di Cancerologia (SIC), Roma, 4-7 ottobre 2010
Deficiency of argininosuccinate synthetase expression confers sensitivity to arginine depletion with arginine deiminase in glioblastomas
Posted on 9 dicembre 2014
Syed N., Roncaroli F., Janczar K., O’Neill K., Lo Nigro C., Lattanzio L., Monteverde M., Schmid P., Szlosarek P., CrookT.: “Deficiency of argininosuccinate synthetase expression confers sensitivity to arginine depletion with arginine deiminase in glioblastomas”, AACR Meeting Genetics and Biology of Cancer Cells, 13-15 dicembre 20